Ivan M. Lieberburg
Direktor/Vorstandsmitglied bei Tavistock Life Sciences Co.
Aktive Positionen von Ivan M. Lieberburg
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Tavistock Group, Inc.
Tavistock Group, Inc. Financial ConglomeratesFinance Tavistock Group, Inc. provides investment services. Its seeks to invest in real estate, hotels, restaurants, healthcare, energy, life sciences, sports and sports ventures. The firm primarily invests in Western Europe, Eastern Europe, United States, South America, Australia, and Caribbean. It also seeks to invest through personal capital. Tavistock Group was founded by Joseph Lewis and is headquartered in Nassau, Bahamas. | Corporate Officer/Principal | 29.06.2009 | - |
The University of California, San Francisco | Corporate Officer/Principal | 29.06.2009 | - |
Tavistock Life Sciences Co.
Tavistock Life Sciences Co. Investment ManagersFinance Tavistock Life Sciences Co (Tavistock Life Sciences Co.) is a venture capital firm founded in 2002. The firm is headquartered in San Diego, California. | Direktor/Vorstandsmitglied | 01.05.2009 | - |
Karriereverlauf von Ivan M. Lieberburg
Ehemalige bekannte Positionen von Ivan M. Lieberburg
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ADAMAS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.01.2004 | 20.11.2020 |
Independent Dir/Board Member | 01.01.2004 | 20.11.2020 | |
Balance Therapeutics, Inc.
Balance Therapeutics, Inc. BiotechnologyHealth Technology Balance Therapeutics, Inc. develops therapeutics to address conditions of intellectual disability. Its pharmacological approach, based on technology licensed from Stanford University, hypothesizes that restoring the proper balance between inhibition and excitation at the neuronal synapse by antagonizing excessive inhibitory circuits could result in the appropriate plasticity for memory and learning to occur in many conditions of intellectual disability. The company was founded by Lyndon Lien, Craig Garner and Daniel Wetmore in 2009 and is headquartered in San Bruno, CA. | Direktor/Vorstandsmitglied | 01.01.2010 | 31.12.2015 |
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1987 | 01.01.2009 |
Icahn School of Medicine at Mount Sinai | Corporate Officer/Principal | 01.09.1987 | 01.09.1987 |
Athena Neurosciences LLC
Athena Neurosciences LLC Miscellaneous Commercial ServicesCommercial Services Athena Neurosciences LLC operates as a research-based pharmaceutical company committed to the field of neurology. It develops therapeutic and diagnostic products. The company was founded by David Rowley-Jones, Larry C. Fritz, and Larry A. Bock in 1986 and is headquartered in Allegan, MI. | Corporate Officer/Principal | 01.01.1987 | - |
ONTRAK, INC. | Direktor/Vorstandsmitglied | 01.01.2003 | - |
Ausbildung von Ivan M. Lieberburg
Cornell University | Undergraduate Degree |
The Rockefeller University | Doctorate Degree |
The University of Miami Leonard M. Miller School of Medicine | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 12 |
Bahamas | 2 |
Operativ
Director/Board Member | 4 |
Corporate Officer/Principal | 4 |
Doctorate Degree | 3 |
Sektoral
Consumer Services | 6 |
Health Technology | 4 |
Finance | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ONTRAK, INC. | Health Services |
Private Unternehmen | 6 |
---|---|
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
Adamas Pharmaceuticals LLC
Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |
Tavistock Group, Inc.
Tavistock Group, Inc. Financial ConglomeratesFinance Tavistock Group, Inc. provides investment services. Its seeks to invest in real estate, hotels, restaurants, healthcare, energy, life sciences, sports and sports ventures. The firm primarily invests in Western Europe, Eastern Europe, United States, South America, Australia, and Caribbean. It also seeks to invest through personal capital. Tavistock Group was founded by Joseph Lewis and is headquartered in Nassau, Bahamas. | Finance |
Tavistock Life Sciences Co.
Tavistock Life Sciences Co. Investment ManagersFinance Tavistock Life Sciences Co (Tavistock Life Sciences Co.) is a venture capital firm founded in 2002. The firm is headquartered in San Diego, California. | Finance |
Balance Therapeutics, Inc.
Balance Therapeutics, Inc. BiotechnologyHealth Technology Balance Therapeutics, Inc. develops therapeutics to address conditions of intellectual disability. Its pharmacological approach, based on technology licensed from Stanford University, hypothesizes that restoring the proper balance between inhibition and excitation at the neuronal synapse by antagonizing excessive inhibitory circuits could result in the appropriate plasticity for memory and learning to occur in many conditions of intellectual disability. The company was founded by Lyndon Lien, Craig Garner and Daniel Wetmore in 2009 and is headquartered in San Bruno, CA. | Health Technology |
Athena Neurosciences LLC
Athena Neurosciences LLC Miscellaneous Commercial ServicesCommercial Services Athena Neurosciences LLC operates as a research-based pharmaceutical company committed to the field of neurology. It develops therapeutic and diagnostic products. The company was founded by David Rowley-Jones, Larry C. Fritz, and Larry A. Bock in 1986 and is headquartered in Allegan, MI. | Commercial Services |
- Börse
- Insiders
- Ivan M. Lieberburg
- Erfahrung